缩写名/全名 |
TUMORI J
Tumori J |
||||||||||||
ISSN号 | 0300-8916 | ||||||||||||
研究方向 | - | ||||||||||||
影响因子 | 2015:1.071, 2016:1.233, 2017:1.304, 2018:1.234, 2019:1.707, | ||||||||||||
出版国家 | Italy | ||||||||||||
出版周期 | |||||||||||||
年文章数 | 70 | ||||||||||||
出版年份 | 0 | ||||||||||||
是否OA | No | ||||||||||||
审稿周期(仅供参考) | |||||||||||||
录用比例 | |||||||||||||
投稿链接 | https://uk.sagepub.com/en-gb/asi/tumori-journal/journal203463#submission-guidelines | ||||||||||||
投稿官网 | https://journals.sagepub.com/home/tmj | ||||||||||||
h-index | |||||||||||||
CiteScore |
|
||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0300-8916%5BISSN%5D | ||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Semaphorin 4D promotes the proliferation and metastasis of bladder cancer by activating the PI3K/AKT pathway. Author: Lu JJ1, Su YW1, Wang CJ2, Li DF1, Zhou L1. Journal: Tumori. 2019 Jan 24:300891618811280. doi: 10.1177/0300891618811280. [Epub ahead of print] PubMed DOI |
2. | Clinical features and treatment of patients with lung adenocarcinoma with bone marrow metastasis. Author: Wang D1, Luo Y2, Shen D1, Yang L3, Liu HY4, Che YQ1. Journal: Tumori. 2019 Apr 1:300891619839864. doi: 10.1177/0300891619839864. [Epub ahead of print] PubMed DOI |
3. | Anesthetic management of radical nephrectomy in patients with renal cell carcinoma involving renal vein or inferior vena cava. Author: Chen K1, Wang J1, Dai J1, Luo A1, Tian Y1, Guan Z2, Wang X1. Journal: Tumori. 2019 Apr 2:300891619839295. doi: 10.1177/0300891619839295. [Epub ahead of print] PubMed DOI |
4. | Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients. Author: Jiang Y1, Miao Z1, Wang J2, Chen J1, Lv Y1, Xing D1, Wang X1, Wang Y1, Cao Z1, Zhao Z1. Journal: Tumori. 2019 Apr 4:300891619839475. doi: 10.1177/0300891619839475. [Epub ahead of print] PubMed DOI |
5. | Association of genetic polymorphisms in PRKDC and XRCC4 with risk of ESCC in a high-incidence region of North China. Author: Yang HL, Qiao DD, Li K, Cheng XL, Yang J, Zhao JJ, Xu CQ, Li YQ. Journal: Tumori. 2016 Apr 18;102(2):131-4. doi: 10.5301/tj.5000306. Epub 2015 Jun 29. PubMed |
6. | The natural compound gambogic acid radiosensitizes nasopharyngeal carcinoma cells under hypoxic conditions. Author: Yang M, Yang Y, Cui H, Guan Z, Yang Y, Zhang H, Chen X, Zhu H, Yang X, Cai J, Cheng H, Sun X. Journal: Tumori. 2016 Apr 18;102(2):135-43. doi: 10.5301/tj.5000411. Epub 2015 Sep 10. PubMed |
7. | Polymorphism rs144848 in BRCA2 may reduce lung cancer risk in women: a case-control study in southeast China. Author: Lin Y, He F, Zhang X, Yu T, Liu Z, Cai L. Journal: Tumori. 2016 Apr 18;102(2):150-5. doi: 10.5301/tj.5000473. Epub 2016 Feb 15. PubMed |
8. | Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis. Author: Li L, Tian J, Liu P, Wang X, Zhu Z. Journal: Tumori. 2016 Jun 2;2016(3):301-10. doi: 10.5301/tj.5000491. Epub 2016 Mar 22. PubMed |
9. | Cost-effectiveness analysis of treatments for metastatic pancreatic cancer based on PRODIGE and MPACT trials. Author: Zhou J, Zhao R, Wen F, Zhang P, Wu Y, Tang R, Chen H, Zhang J, Li Q. Journal: Tumori. 2016 Jun 2;2016(3):294-300. doi: 10.5301/tj.5000499. Epub 2016 Apr 5. PubMed |
10. | Anti-hMAM monoclonal antibodies evaluated in breast and non-breast tissues for differential diagnosis implication. Author: Lv X, Feng X, Hao X, Meng D, Yang X, Xiu B, Chen K, Lu Y, Zhang H, Zeng Y, Huang Y. Journal: Tumori. 2016 Jun 2;2016(3):264-9. doi: 10.5301/tj.5000496. Epub 2016 Apr 21. PubMed |
|
|